Rather than outright banning compounded GLP-1 medications, expert associations can contribute to the solution by creating a seal of approval, recognizing high-quality compounded medications
Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy
GLP-1 receptor agonists stimulate insulin release from the pancreas only when blood glucose is elevated, suppress glucagon (which reduces liver glucose production), and slow gastric emptying to moderate glucose absorption after meals
References Rosenstock J, et al
How GLP-1 Programs Work: Complete an online health questionnaire Consult with a licensed healthcare provider via video or messaging Receive a prescription if you qualify (typically BMI of 30+, or 27+ with weight-related conditions) Get medication delivered to your home or local pharmacy Access ongoing support through the platform Most telehealth GLP-1 programs offer either brand-name medications (Ozempic, Wegovy, Mounjaro, Zepbound) or compounded versions of semaglutide and tirzepatide